nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—CYP2C9—brain cancer	0.454	1	CbGaD
Nicotine—CYP2D6—Lomustine—brain cancer	0.0409	0.183	CbGbCtD
Nicotine—CYP1A2—Carmustine—brain cancer	0.0405	0.181	CbGbCtD
Nicotine—CYP2D6—Hydroxyurea—brain cancer	0.031	0.139	CbGbCtD
Nicotine—CYP3A4—Temozolomide—brain cancer	0.0306	0.137	CbGbCtD
Nicotine—CYP3A4—Lomustine—brain cancer	0.026	0.116	CbGbCtD
Nicotine—CYP2E1—Etoposide—brain cancer	0.0207	0.0928	CbGbCtD
Nicotine—CYP2A13—nose—brain cancer	0.0168	0.106	CbGeAlD
Nicotine—CYP2C8—Etoposide—brain cancer	0.0155	0.0693	CbGbCtD
Nicotine—CHRNA9—cochlea—brain cancer	0.0141	0.0884	CbGeAlD
Nicotine—CHRNA9—internal ear—brain cancer	0.0134	0.0838	CbGeAlD
Nicotine—CYP1A2—Etoposide—brain cancer	0.012	0.0537	CbGbCtD
Nicotine—CHRNB3—pons—brain cancer	0.00724	0.0454	CbGeAlD
Nicotine—CHAT—cerebellar cortex—brain cancer	0.0071	0.0445	CbGeAlD
Nicotine—CYP3A4—Etoposide—brain cancer	0.00628	0.0281	CbGbCtD
Nicotine—CHRNA10—internal ear—brain cancer	0.00591	0.0371	CbGeAlD
Nicotine—CHAT—cranial nerve—brain cancer	0.00508	0.0319	CbGeAlD
Nicotine—CHAT—pons—brain cancer	0.00502	0.0315	CbGeAlD
Nicotine—CHAT—telencephalic ventricle—brain cancer	0.00413	0.0259	CbGeAlD
Nicotine—CHRNB3—ganglion—brain cancer	0.00371	0.0233	CbGeAlD
Nicotine—CHRNA6—ganglion—brain cancer	0.0031	0.0194	CbGeAlD
Nicotine—CHRNB3—hindbrain—brain cancer	0.00281	0.0176	CbGeAlD
Nicotine—CHRNA4—cochlea—brain cancer	0.0028	0.0175	CbGeAlD
Nicotine—CHAT—ganglion—brain cancer	0.00257	0.0161	CbGeAlD
Nicotine—CHAT—hindbrain—brain cancer	0.00195	0.0122	CbGeAlD
Nicotine—CHRNA4—telencephalic ventricle—brain cancer	0.00179	0.0112	CbGeAlD
Nicotine—CHRNB3—brainstem—brain cancer	0.00161	0.0101	CbGeAlD
Nicotine—CHRNB3—telencephalon—brain cancer	0.00143	0.00897	CbGeAlD
Nicotine—CHRNA6—brainstem—brain cancer	0.00135	0.00844	CbGeAlD
Nicotine—CHRNA6—telencephalon—brain cancer	0.00119	0.00749	CbGeAlD
Nicotine—CYP2A13—endocrine gland—brain cancer	0.00116	0.00727	CbGeAlD
Nicotine—CHRNA7—ganglion—brain cancer	0.00113	0.00707	CbGeAlD
Nicotine—CHAT—brainstem—brain cancer	0.00112	0.00701	CbGeAlD
Nicotine—CHRNA4—ganglion—brain cancer	0.00111	0.00697	CbGeAlD
Nicotine—CHRNB3—midbrain—brain cancer	0.00103	0.00645	CbGeAlD
Nicotine—CHAT—telencephalon—brain cancer	0.000992	0.00622	CbGeAlD
Nicotine—CHRNA5—head—brain cancer	0.000982	0.00615	CbGeAlD
Nicotine—SLC22A1—ganglion—brain cancer	0.000939	0.00589	CbGeAlD
Nicotine—CHRNA5—central nervous system—brain cancer	0.000896	0.00562	CbGeAlD
Nicotine—CHRNB3—head—brain cancer	0.000891	0.00559	CbGeAlD
Nicotine—CHRNA6—midbrain—brain cancer	0.000858	0.00538	CbGeAlD
Nicotine—CHRNA4—hindbrain—brain cancer	0.000843	0.00529	CbGeAlD
Nicotine—MAOB—ganglion—brain cancer	0.000831	0.00521	CbGeAlD
Nicotine—CHRNB3—central nervous system—brain cancer	0.000814	0.0051	CbGeAlD
Nicotine—CHRNB3—cerebellum—brain cancer	0.000795	0.00499	CbGeAlD
Nicotine—CHAT—medulla oblongata—brain cancer	0.00078	0.00489	CbGeAlD
Nicotine—CHRNA6—head—brain cancer	0.000744	0.00466	CbGeAlD
Nicotine—CHAT—midbrain—brain cancer	0.000712	0.00447	CbGeAlD
Nicotine—CHRNA5—brain—brain cancer	0.000711	0.00446	CbGeAlD
Nicotine—MAOA—ganglion—brain cancer	0.000709	0.00444	CbGeAlD
Nicotine—CHAT—spinal cord—brain cancer	0.000695	0.00436	CbGeAlD
Nicotine—Sweating increased—Procarbazine—brain cancer	0.000694	0.00724	CcSEcCtD
Nicotine—CHRNB2—telencephalon—brain cancer	0.000686	0.0043	CbGeAlD
Nicotine—Tingling sensation—Etoposide—brain cancer	0.000683	0.00713	CcSEcCtD
Nicotine—CHRNA6—central nervous system—brain cancer	0.000679	0.00426	CbGeAlD
Nicotine—CHRNB4—head—brain cancer	0.000675	0.00424	CbGeAlD
Nicotine—Dermatitis bullous—Hydroxyurea—brain cancer	0.000668	0.00696	CcSEcCtD
Nicotine—Influenza like illness—Temozolomide—brain cancer	0.000667	0.00696	CcSEcCtD
Nicotine—CHRNA6—cerebellum—brain cancer	0.000664	0.00416	CbGeAlD
Nicotine—Numbness—Etoposide—brain cancer	0.000663	0.00691	CcSEcCtD
Nicotine—CHRNB3—brain—brain cancer	0.000646	0.00405	CbGeAlD
Nicotine—Sensory loss—Etoposide—brain cancer	0.000634	0.00662	CcSEcCtD
Nicotine—MAOB—hindbrain—brain cancer	0.00063	0.00395	CbGeAlD
Nicotine—CHAT—endocrine gland—brain cancer	0.000626	0.00392	CbGeAlD
Nicotine—Pain—Carboplatin—brain cancer	0.000624	0.00651	CcSEcCtD
Nicotine—Chest discomfort—Etoposide—brain cancer	0.000621	0.00648	CcSEcCtD
Nicotine—Abnormal vision—Carmustine—brain cancer	0.00062	0.00646	CcSEcCtD
Nicotine—Stomatitis—Procarbazine—brain cancer	0.000619	0.00646	CcSEcCtD
Nicotine—CHAT—head—brain cancer	0.000618	0.00387	CbGeAlD
Nicotine—CHRNB4—central nervous system—brain cancer	0.000617	0.00387	CbGeAlD
Nicotine—Mental disability—Carmustine—brain cancer	0.000617	0.00643	CcSEcCtD
Nicotine—Epistaxis—Procarbazine—brain cancer	0.000599	0.00625	CcSEcCtD
Nicotine—Abnormal vision—Temozolomide—brain cancer	0.000599	0.00625	CcSEcCtD
Nicotine—Mental disability—Temozolomide—brain cancer	0.000596	0.00621	CcSEcCtD
Nicotine—CHRNA10—head—brain cancer	0.000595	0.00373	CbGeAlD
Nicotine—Ear pain—Temozolomide—brain cancer	0.000584	0.00609	CcSEcCtD
Nicotine—Body temperature increased—Carboplatin—brain cancer	0.000577	0.00601	CcSEcCtD
Nicotine—CHAT—central nervous system—brain cancer	0.000564	0.00354	CbGeAlD
Nicotine—CHRNB2—pituitary gland—brain cancer	0.000559	0.0035	CbGeAlD
Nicotine—CHAT—cerebellum—brain cancer	0.000551	0.00346	CbGeAlD
Nicotine—Amnesia—Carmustine—brain cancer	0.000549	0.00573	CcSEcCtD
Nicotine—Nasal congestion—Temozolomide—brain cancer	0.000547	0.00571	CcSEcCtD
Nicotine—CHRNB2—medulla oblongata—brain cancer	0.000539	0.00338	CbGeAlD
Nicotine—CHRNA6—brain—brain cancer	0.000539	0.00338	CbGeAlD
Nicotine—CHRFAM7A—telencephalon—brain cancer	0.000538	0.00337	CbGeAlD
Nicotine—MAOA—hindbrain—brain cancer	0.000538	0.00337	CbGeAlD
Nicotine—Hot flush—Temozolomide—brain cancer	0.000533	0.00556	CcSEcCtD
Nicotine—Amnesia—Temozolomide—brain cancer	0.00053	0.00553	CcSEcCtD
Nicotine—Flushing—Procarbazine—brain cancer	0.000529	0.00552	CcSEcCtD
Nicotine—Menopausal symptoms—Temozolomide—brain cancer	0.000528	0.00551	CcSEcCtD
Nicotine—Arrhythmia—Procarbazine—brain cancer	0.000509	0.00531	CcSEcCtD
Nicotine—Body temperature increased—Lomustine—brain cancer	0.000504	0.00526	CcSEcCtD
Nicotine—Weight increased—Hydroxyurea—brain cancer	0.000502	0.00523	CcSEcCtD
Nicotine—Mouth ulceration—Etoposide—brain cancer	0.000497	0.00518	CcSEcCtD
Nicotine—CHRNB2—midbrain—brain cancer	0.000493	0.00309	CbGeAlD
Nicotine—Affect lability—Temozolomide—brain cancer	0.000491	0.00512	CcSEcCtD
Nicotine—CHRNB4—brain—brain cancer	0.000489	0.00307	CbGeAlD
Nicotine—Tension—Procarbazine—brain cancer	0.000487	0.00508	CcSEcCtD
Nicotine—CHRNA4—brainstem—brain cancer	0.000483	0.00303	CbGeAlD
Nicotine—Nervousness—Procarbazine—brain cancer	0.000482	0.00503	CcSEcCtD
Nicotine—CHRNB2—spinal cord—brain cancer	0.000481	0.00301	CbGeAlD
Nicotine—Stomatitis—Hydroxyurea—brain cancer	0.000479	0.005	CcSEcCtD
Nicotine—Mood swings—Temozolomide—brain cancer	0.000472	0.00492	CcSEcCtD
Nicotine—Tremor—Procarbazine—brain cancer	0.000465	0.00485	CcSEcCtD
Nicotine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000458	0.00676	CbGpPWpGaD
Nicotine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000448	0.00662	CbGpPWpGaD
Nicotine—CHAT—brain—brain cancer	0.000448	0.00281	CbGeAlD
Nicotine—Dysphagia—Carmustine—brain cancer	0.000446	0.00465	CcSEcCtD
Nicotine—Syncope—Procarbazine—brain cancer	0.000445	0.00464	CcSEcCtD
Nicotine—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000443	0.00654	CbGpPWpGaD
Nicotine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000439	0.00648	CbGpPWpGaD
Nicotine—CYP19A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000437	0.00645	CbGpPWpGaD
Nicotine—Loss of consciousness—Procarbazine—brain cancer	0.000436	0.00455	CcSEcCtD
Nicotine—CHRNA7—telencephalon—brain cancer	0.000435	0.00273	CbGeAlD
Nicotine—Cough—Procarbazine—brain cancer	0.000433	0.00452	CcSEcCtD
Nicotine—Dysphagia—Temozolomide—brain cancer	0.000431	0.00449	CcSEcCtD
Nicotine—Convulsion—Procarbazine—brain cancer	0.00043	0.00449	CcSEcCtD
Nicotine—CHRNA4—telencephalon—brain cancer	0.000429	0.00269	CbGeAlD
Nicotine—Hypertension—Procarbazine—brain cancer	0.000429	0.00447	CcSEcCtD
Nicotine—CHRNB2—head—brain cancer	0.000427	0.00268	CbGeAlD
Nicotine—Myalgia—Procarbazine—brain cancer	0.000423	0.00441	CcSEcCtD
Nicotine—Arthralgia—Procarbazine—brain cancer	0.000423	0.00441	CcSEcCtD
Nicotine—Anxiety—Procarbazine—brain cancer	0.000421	0.00439	CcSEcCtD
Nicotine—CHRNA3—endocrine gland—brain cancer	0.00042	0.00263	CbGeAlD
Nicotine—Sweating increased—Temozolomide—brain cancer	0.00042	0.00438	CcSEcCtD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—HES5—brain cancer	0.000419	0.00619	CbGpPWpGaD
Nicotine—CHRNA3—head—brain cancer	0.000414	0.0026	CbGeAlD
Nicotine—Bronchitis—Temozolomide—brain cancer	0.000414	0.00432	CcSEcCtD
Nicotine—Dry mouth—Procarbazine—brain cancer	0.000413	0.00431	CcSEcCtD
Nicotine—Cardiac failure—Etoposide—brain cancer	0.000409	0.00426	CcSEcCtD
Nicotine—Confusional state—Procarbazine—brain cancer	0.000409	0.00426	CcSEcCtD
Nicotine—Vomiting—Lomustine—brain cancer	0.000406	0.00423	CcSEcCtD
Nicotine—Oedema—Procarbazine—brain cancer	0.000405	0.00423	CcSEcCtD
Nicotine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000403	0.00595	CbGpPWpGaD
Nicotine—Shock—Procarbazine—brain cancer	0.000399	0.00416	CcSEcCtD
Nicotine—Tachycardia—Procarbazine—brain cancer	0.000395	0.00412	CcSEcCtD
Nicotine—Weight increased—Temozolomide—brain cancer	0.000392	0.00409	CcSEcCtD
Nicotine—Hyperhidrosis—Procarbazine—brain cancer	0.000392	0.00409	CcSEcCtD
Nicotine—CHRNA2—endocrine gland—brain cancer	0.00039	0.00245	CbGeAlD
Nicotine—CHRNB2—central nervous system—brain cancer	0.00039	0.00245	CbGeAlD
Nicotine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000388	0.00573	CbGpPWpGaD
Nicotine—Stomatitis—Carmustine—brain cancer	0.000387	0.00404	CcSEcCtD
Nicotine—CHRNA2—head—brain cancer	0.000385	0.00242	CbGeAlD
Nicotine—Erythema—Hydroxyurea—brain cancer	0.000384	0.00401	CcSEcCtD
Nicotine—CHRNB2—cerebellum—brain cancer	0.000381	0.00239	CbGeAlD
Nicotine—Nausea—Lomustine—brain cancer	0.000379	0.00395	CcSEcCtD
Nicotine—Hypotension—Procarbazine—brain cancer	0.000379	0.00395	CcSEcCtD
Nicotine—CHRNA3—central nervous system—brain cancer	0.000378	0.00237	CbGeAlD
Nicotine—Stomatitis—Temozolomide—brain cancer	0.000374	0.0039	CcSEcCtD
Nicotine—CHRNA3—cerebellum—brain cancer	0.00037	0.00232	CbGeAlD
Nicotine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000369	0.00385	CcSEcCtD
Nicotine—MAOA—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000368	0.00544	CbGpPWpGaD
Nicotine—Insomnia—Procarbazine—brain cancer	0.000366	0.00382	CcSEcCtD
Nicotine—Paraesthesia—Procarbazine—brain cancer	0.000364	0.00379	CcSEcCtD
Nicotine—SLC22A1—telencephalon—brain cancer	0.000362	0.00227	CbGeAlD
Nicotine—MAOB—brainstem—brain cancer	0.000361	0.00226	CbGeAlD
Nicotine—Sinusitis—Temozolomide—brain cancer	0.00036	0.00376	CcSEcCtD
Nicotine—Somnolence—Procarbazine—brain cancer	0.00036	0.00376	CcSEcCtD
Nicotine—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000359	0.0053	CbGpPWpGaD
Nicotine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000356	0.00372	CcSEcCtD
Nicotine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000355	0.00525	CbGpPWpGaD
Nicotine—Hypoaesthesia—Carmustine—brain cancer	0.000355	0.0037	CcSEcCtD
Nicotine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000353	0.00521	CbGpPWpGaD
Nicotine—CHRNA2—central nervous system—brain cancer	0.000352	0.0022	CbGeAlD
Nicotine—Oedema peripheral—Carmustine—brain cancer	0.000351	0.00367	CcSEcCtD
Nicotine—Fatigue—Procarbazine—brain cancer	0.000349	0.00364	CcSEcCtD
Nicotine—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000348	0.00514	CbGpPWpGaD
Nicotine—Malaise—Hydroxyurea—brain cancer	0.000346	0.00361	CcSEcCtD
Nicotine—Constipation—Procarbazine—brain cancer	0.000346	0.00361	CcSEcCtD
Nicotine—Pain—Procarbazine—brain cancer	0.000346	0.00361	CcSEcCtD
Nicotine—Dysphagia—Etoposide—brain cancer	0.000345	0.0036	CcSEcCtD
Nicotine—Visual impairment—Carmustine—brain cancer	0.000344	0.00359	CcSEcCtD
Nicotine—CHRNA2—cerebellum—brain cancer	0.000344	0.00215	CbGeAlD
Nicotine—Hypoaesthesia—Temozolomide—brain cancer	0.000343	0.00358	CcSEcCtD
Nicotine—Pharyngitis—Temozolomide—brain cancer	0.000342	0.00357	CcSEcCtD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—HES5—brain cancer	0.000342	0.00505	CbGpPWpGaD
Nicotine—Oedema peripheral—Temozolomide—brain cancer	0.00034	0.00354	CcSEcCtD
Nicotine—CHRFAM7A—endocrine gland—brain cancer	0.000339	0.00213	CbGeAlD
Nicotine—Bronchospasm—Etoposide—brain cancer	0.000339	0.00354	CcSEcCtD
Nicotine—CYP19A1—Ovarian Infertility Genes—ESR2—brain cancer	0.000339	0.005	CbGpPWpGaD
Nicotine—Sweating increased—Etoposide—brain cancer	0.000336	0.0035	CcSEcCtD
Nicotine—CHRFAM7A—head—brain cancer	0.000335	0.0021	CbGeAlD
Nicotine—Feeling abnormal—Procarbazine—brain cancer	0.000334	0.00348	CcSEcCtD
Nicotine—CHAT—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000333	0.00491	CbGpPWpGaD
Nicotine—Convulsion—Hydroxyurea—brain cancer	0.000333	0.00347	CcSEcCtD
Nicotine—Visual impairment—Temozolomide—brain cancer	0.000332	0.00347	CcSEcCtD
Nicotine—Gastrointestinal pain—Procarbazine—brain cancer	0.000331	0.00346	CcSEcCtD
Nicotine—Flushing—Carmustine—brain cancer	0.000331	0.00345	CcSEcCtD
Nicotine—Discomfort—Hydroxyurea—brain cancer	0.000323	0.00337	CcSEcCtD
Nicotine—Urticaria—Procarbazine—brain cancer	0.000322	0.00336	CcSEcCtD
Nicotine—MAOB—telencephalon—brain cancer	0.000321	0.00201	CbGeAlD
Nicotine—Body temperature increased—Procarbazine—brain cancer	0.00032	0.00334	CcSEcCtD
Nicotine—Abdominal pain—Procarbazine—brain cancer	0.00032	0.00334	CcSEcCtD
Nicotine—Cardiac disorder—Temozolomide—brain cancer	0.00032	0.00334	CcSEcCtD
Nicotine—Flushing—Temozolomide—brain cancer	0.00032	0.00334	CcSEcCtD
Nicotine—CYP2D6—hindbrain—brain cancer	0.000319	0.002	CbGeAlD
Nicotine—Arrhythmia—Carmustine—brain cancer	0.000319	0.00332	CcSEcCtD
Nicotine—Oedema—Hydroxyurea—brain cancer	0.000314	0.00327	CcSEcCtD
Nicotine—Mental disorder—Carmustine—brain cancer	0.000313	0.00326	CcSEcCtD
Nicotine—MAOB—Biological oxidations—CYP2C9—brain cancer	0.000312	0.0046	CbGpPWpGaD
Nicotine—Immune system disorder—Temozolomide—brain cancer	0.000311	0.00325	CcSEcCtD
Nicotine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000311	0.0046	CbGpPWpGaD
Nicotine—Mediastinal disorder—Temozolomide—brain cancer	0.000311	0.00324	CcSEcCtD
Nicotine—Erythema—Carmustine—brain cancer	0.000311	0.00324	CcSEcCtD
Nicotine—SLC22A4—pituitary gland—brain cancer	0.00031	0.00194	CbGeAlD
Nicotine—CHRNB2—brain—brain cancer	0.00031	0.00194	CbGeAlD
Nicotine—MAOA—brainstem—brain cancer	0.000308	0.00193	CbGeAlD
Nicotine—CHRNA4—midbrain—brain cancer	0.000308	0.00193	CbGeAlD
Nicotine—Nervous system disorder—Hydroxyurea—brain cancer	0.000307	0.00321	CcSEcCtD
Nicotine—CHRFAM7A—central nervous system—brain cancer	0.000306	0.00192	CbGeAlD
Nicotine—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000304	0.00449	CbGpPWpGaD
Nicotine—Mental disorder—Temozolomide—brain cancer	0.000302	0.00315	CcSEcCtD
Nicotine—CHRNA4—spinal cord—brain cancer	0.0003	0.00188	CbGeAlD
Nicotine—Back pain—Carmustine—brain cancer	0.0003	0.00313	CcSEcCtD
Nicotine—CHRNA3—brain—brain cancer	0.0003	0.00188	CbGeAlD
Nicotine—Erythema—Temozolomide—brain cancer	0.0003	0.00313	CcSEcCtD
Nicotine—Stomatitis—Etoposide—brain cancer	0.0003	0.00312	CcSEcCtD
Nicotine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000299	0.00442	CbGpPWpGaD
Nicotine—Hypersensitivity—Procarbazine—brain cancer	0.000299	0.00311	CcSEcCtD
Nicotine—Dysgeusia—Temozolomide—brain cancer	0.000294	0.00307	CcSEcCtD
Nicotine—Tremor—Carmustine—brain cancer	0.000291	0.00304	CcSEcCtD
Nicotine—Asthenia—Procarbazine—brain cancer	0.000291	0.00303	CcSEcCtD
Nicotine—Back pain—Temozolomide—brain cancer	0.00029	0.00303	CcSEcCtD
Nicotine—SLC22A3—gonad—brain cancer	0.000289	0.00181	CbGeAlD
Nicotine—Pruritus—Procarbazine—brain cancer	0.000287	0.00299	CcSEcCtD
Nicotine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000286	0.00422	CbGpPWpGaD
Nicotine—Agitation—Carmustine—brain cancer	0.000285	0.00298	CcSEcCtD
Nicotine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000285	0.0042	CbGpPWpGaD
Nicotine—CYP19A1—gonad—brain cancer	0.000284	0.00178	CbGeAlD
Nicotine—MAOA—Oxidative Stress—SOD2—brain cancer	0.000283	0.00418	CbGpPWpGaD
Nicotine—Tremor—Temozolomide—brain cancer	0.000281	0.00293	CcSEcCtD
Nicotine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000281	0.00414	CbGpPWpGaD
Nicotine—Dyspnoea—Hydroxyurea—brain cancer	0.00028	0.00292	CcSEcCtD
Nicotine—CHRNA2—brain—brain cancer	0.000279	0.00175	CbGeAlD
Nicotine—Somnolence—Hydroxyurea—brain cancer	0.000279	0.00291	CcSEcCtD
Nicotine—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000279	0.00411	CbGpPWpGaD
Nicotine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000279	0.00411	CbGpPWpGaD
Nicotine—Ill-defined disorder—Temozolomide—brain cancer	0.000278	0.0029	CcSEcCtD
Nicotine—Diarrhoea—Procarbazine—brain cancer	0.000277	0.00289	CcSEcCtD
Nicotine—Dyspepsia—Hydroxyurea—brain cancer	0.000276	0.00288	CcSEcCtD
Nicotine—Agitation—Temozolomide—brain cancer	0.000276	0.00288	CcSEcCtD
Nicotine—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000275	0.00406	CbGpPWpGaD
Nicotine—Hypoaesthesia—Etoposide—brain cancer	0.000275	0.00286	CcSEcCtD
Nicotine—Angioedema—Temozolomide—brain cancer	0.000274	0.00286	CcSEcCtD
Nicotine—CHRNA7—endocrine gland—brain cancer	0.000274	0.00172	CbGeAlD
Nicotine—MAOA—telencephalon—brain cancer	0.000273	0.00171	CbGeAlD
Nicotine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000271	0.00282	CcSEcCtD
Nicotine—Malaise—Temozolomide—brain cancer	0.000271	0.00282	CcSEcCtD
Nicotine—CHRNA7—head—brain cancer	0.000271	0.0017	CbGeAlD
Nicotine—CHRNA4—endocrine gland—brain cancer	0.00027	0.0017	CbGeAlD
Nicotine—Fatigue—Hydroxyurea—brain cancer	0.00027	0.00282	CcSEcCtD
Nicotine—Vertigo—Temozolomide—brain cancer	0.00027	0.00281	CcSEcCtD
Nicotine—Convulsion—Carmustine—brain cancer	0.000269	0.00281	CcSEcCtD
Nicotine—Hypertension—Carmustine—brain cancer	0.000268	0.0028	CcSEcCtD
Nicotine—Pain—Hydroxyurea—brain cancer	0.000268	0.0028	CcSEcCtD
Nicotine—Constipation—Hydroxyurea—brain cancer	0.000268	0.0028	CcSEcCtD
Nicotine—Dizziness—Procarbazine—brain cancer	0.000268	0.00279	CcSEcCtD
Nicotine—CHRNA4—head—brain cancer	0.000267	0.00167	CbGeAlD
Nicotine—SLC22A4—spinal cord—brain cancer	0.000267	0.00167	CbGeAlD
Nicotine—Palpitations—Temozolomide—brain cancer	0.000265	0.00277	CcSEcCtD
Nicotine—Myalgia—Carmustine—brain cancer	0.000264	0.00276	CcSEcCtD
Nicotine—Chest pain—Carmustine—brain cancer	0.000264	0.00276	CcSEcCtD
Nicotine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000264	0.0039	CbGpPWpGaD
Nicotine—Anxiety—Carmustine—brain cancer	0.000264	0.00275	CcSEcCtD
Nicotine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000263	0.00388	CbGpPWpGaD
Nicotine—Cough—Temozolomide—brain cancer	0.000262	0.00273	CcSEcCtD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000261	0.00386	CbGpPWpGaD
Nicotine—MAOB—pituitary gland—brain cancer	0.000261	0.00164	CbGeAlD
Nicotine—Convulsion—Temozolomide—brain cancer	0.00026	0.00271	CcSEcCtD
Nicotine—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000259	0.00383	CbGpPWpGaD
Nicotine—Hypertension—Temozolomide—brain cancer	0.000259	0.0027	CcSEcCtD
Nicotine—CHAT—SIDS Susceptibility Pathways—HES1—brain cancer	0.000259	0.00382	CbGpPWpGaD
Nicotine—Feeling abnormal—Hydroxyurea—brain cancer	0.000258	0.0027	CcSEcCtD
Nicotine—Vomiting—Procarbazine—brain cancer	0.000258	0.00269	CcSEcCtD
Nicotine—Flushing—Etoposide—brain cancer	0.000256	0.00267	CcSEcCtD
Nicotine—Cardiac disorder—Etoposide—brain cancer	0.000256	0.00267	CcSEcCtD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000256	0.00377	CbGpPWpGaD
Nicotine—Confusional state—Carmustine—brain cancer	0.000256	0.00267	CcSEcCtD
Nicotine—Arthralgia—Temozolomide—brain cancer	0.000256	0.00267	CcSEcCtD
Nicotine—Myalgia—Temozolomide—brain cancer	0.000256	0.00267	CcSEcCtD
Nicotine—Rash—Procarbazine—brain cancer	0.000255	0.00266	CcSEcCtD
Nicotine—Dermatitis—Procarbazine—brain cancer	0.000255	0.00266	CcSEcCtD
Nicotine—Anxiety—Temozolomide—brain cancer	0.000255	0.00266	CcSEcCtD
Nicotine—Headache—Procarbazine—brain cancer	0.000254	0.00265	CcSEcCtD
Nicotine—Oedema—Carmustine—brain cancer	0.000253	0.00264	CcSEcCtD
Nicotine—Discomfort—Temozolomide—brain cancer	0.000252	0.00263	CcSEcCtD
Nicotine—MAOB—medulla oblongata—brain cancer	0.000252	0.00158	CbGeAlD
Nicotine—Dry mouth—Temozolomide—brain cancer	0.00025	0.00261	CcSEcCtD
Nicotine—Immune system disorder—Etoposide—brain cancer	0.000249	0.0026	CcSEcCtD
Nicotine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000249	0.00367	CbGpPWpGaD
Nicotine—Mediastinal disorder—Etoposide—brain cancer	0.000249	0.00259	CcSEcCtD
Nicotine—Body temperature increased—Hydroxyurea—brain cancer	0.000248	0.00259	CcSEcCtD
Nicotine—Tachycardia—Carmustine—brain cancer	0.000247	0.00258	CcSEcCtD
Nicotine—CHRNA7—central nervous system—brain cancer	0.000247	0.00155	CbGeAlD
Nicotine—Confusional state—Temozolomide—brain cancer	0.000247	0.00258	CcSEcCtD
Nicotine—Oedema—Temozolomide—brain cancer	0.000245	0.00256	CcSEcCtD
Nicotine—Anaphylactic shock—Temozolomide—brain cancer	0.000245	0.00256	CcSEcCtD
Nicotine—CHRNA4—central nervous system—brain cancer	0.000244	0.00153	CbGeAlD
Nicotine—CHRFAM7A—brain—brain cancer	0.000243	0.00152	CbGeAlD
Nicotine—CYP2A6—cerebellum—brain cancer	0.000241	0.00151	CbGeAlD
Nicotine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000241	0.00356	CbGpPWpGaD
Nicotine—Nausea—Procarbazine—brain cancer	0.000241	0.00251	CcSEcCtD
Nicotine—Nervous system disorder—Temozolomide—brain cancer	0.00024	0.00251	CcSEcCtD
Nicotine—CHRNA4—cerebellum—brain cancer	0.000238	0.00149	CbGeAlD
Nicotine—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000238	0.00351	CbGpPWpGaD
Nicotine—Hypotension—Carmustine—brain cancer	0.000237	0.00247	CcSEcCtD
Nicotine—Hyperhidrosis—Temozolomide—brain cancer	0.000237	0.00247	CcSEcCtD
Nicotine—Dysgeusia—Etoposide—brain cancer	0.000235	0.00245	CcSEcCtD
Nicotine—Back pain—Etoposide—brain cancer	0.000232	0.00242	CcSEcCtD
Nicotine—Hypersensitivity—Hydroxyurea—brain cancer	0.000231	0.00241	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000231	0.00241	CcSEcCtD
Nicotine—Muscle spasms—Etoposide—brain cancer	0.000231	0.00241	CcSEcCtD
Nicotine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000231	0.0034	CbGpPWpGaD
Nicotine—MAOB—midbrain—brain cancer	0.00023	0.00144	CbGeAlD
Nicotine—MAOA—SIDS Susceptibility Pathways—HES5—brain cancer	0.00023	0.00339	CbGpPWpGaD
Nicotine—Insomnia—Carmustine—brain cancer	0.000229	0.00239	CcSEcCtD
Nicotine—SLC22A1—endocrine gland—brain cancer	0.000229	0.00143	CbGeAlD
Nicotine—Paraesthesia—Carmustine—brain cancer	0.000228	0.00237	CcSEcCtD
Nicotine—Dyspnoea—Carmustine—brain cancer	0.000226	0.00236	CcSEcCtD
Nicotine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000226	0.00333	CbGpPWpGaD
Nicotine—SLC22A1—head—brain cancer	0.000226	0.00142	CbGeAlD
Nicotine—Somnolence—Carmustine—brain cancer	0.000225	0.00235	CcSEcCtD
Nicotine—Asthenia—Hydroxyurea—brain cancer	0.000225	0.00235	CcSEcCtD
Nicotine—MAOB—spinal cord—brain cancer	0.000225	0.00141	CbGeAlD
Nicotine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000223	0.00233	CcSEcCtD
Nicotine—Ill-defined disorder—Etoposide—brain cancer	0.000223	0.00232	CcSEcCtD
Nicotine—MAOA—pituitary gland—brain cancer	0.000223	0.0014	CbGeAlD
Nicotine—Insomnia—Temozolomide—brain cancer	0.000222	0.00231	CcSEcCtD
Nicotine—Paraesthesia—Temozolomide—brain cancer	0.00022	0.00229	CcSEcCtD
Nicotine—Gastrointestinal disorder—Carmustine—brain cancer	0.000219	0.00228	CcSEcCtD
Nicotine—SLC22A3—endocrine gland—brain cancer	0.000218	0.00137	CbGeAlD
Nicotine—Dyspnoea—Temozolomide—brain cancer	0.000218	0.00228	CcSEcCtD
Nicotine—Somnolence—Temozolomide—brain cancer	0.000218	0.00227	CcSEcCtD
Nicotine—Constipation—Carmustine—brain cancer	0.000217	0.00226	CcSEcCtD
Nicotine—Pain—Carmustine—brain cancer	0.000217	0.00226	CcSEcCtD
Nicotine—Malaise—Etoposide—brain cancer	0.000217	0.00226	CcSEcCtD
Nicotine—Vertigo—Etoposide—brain cancer	0.000216	0.00225	CcSEcCtD
Nicotine—SLC22A3—head—brain cancer	0.000216	0.00135	CbGeAlD
Nicotine—Dyspepsia—Temozolomide—brain cancer	0.000216	0.00225	CcSEcCtD
Nicotine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000215	0.00317	CbGpPWpGaD
Nicotine—MAOA—medulla oblongata—brain cancer	0.000215	0.00135	CbGeAlD
Nicotine—CYP19A1—endocrine gland—brain cancer	0.000215	0.00135	CbGeAlD
Nicotine—Diarrhoea—Hydroxyurea—brain cancer	0.000215	0.00224	CcSEcCtD
Nicotine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000214	0.00316	CbGpPWpGaD
Nicotine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000213	0.00314	CbGpPWpGaD
Nicotine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000212	0.00313	CbGpPWpGaD
Nicotine—CYP19A1—head—brain cancer	0.000212	0.00133	CbGeAlD
Nicotine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000211	0.00221	CcSEcCtD
Nicotine—SLC22A4—cerebellum—brain cancer	0.000211	0.00133	CbGeAlD
Nicotine—Fatigue—Temozolomide—brain cancer	0.000211	0.0022	CcSEcCtD
Nicotine—Loss of consciousness—Etoposide—brain cancer	0.000211	0.0022	CcSEcCtD
Nicotine—CHAT—Phospholipid metabolism—PIK3CG—brain cancer	0.000211	0.00311	CbGpPWpGaD
Nicotine—Cough—Etoposide—brain cancer	0.00021	0.00219	CcSEcCtD
Nicotine—Constipation—Temozolomide—brain cancer	0.000209	0.00218	CcSEcCtD
Nicotine—Pain—Temozolomide—brain cancer	0.000209	0.00218	CcSEcCtD
Nicotine—Feeling abnormal—Carmustine—brain cancer	0.000209	0.00218	CcSEcCtD
Nicotine—Convulsion—Etoposide—brain cancer	0.000208	0.00217	CcSEcCtD
Nicotine—Hypertension—Etoposide—brain cancer	0.000207	0.00216	CcSEcCtD
Nicotine—Dizziness—Hydroxyurea—brain cancer	0.000207	0.00216	CcSEcCtD
Nicotine—Gastrointestinal pain—Carmustine—brain cancer	0.000207	0.00216	CcSEcCtD
Nicotine—CYP19A1—Ovarian Infertility Genes—CDK4—brain cancer	0.000206	0.00305	CbGpPWpGaD
Nicotine—SLC22A1—central nervous system—brain cancer	0.000206	0.00129	CbGeAlD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000206	0.00304	CbGpPWpGaD
Nicotine—CYP2E1—telencephalon—brain cancer	0.000205	0.00129	CbGeAlD
Nicotine—SLC22A5—pituitary gland—brain cancer	0.000205	0.00129	CbGeAlD
Nicotine—Chest pain—Etoposide—brain cancer	0.000204	0.00213	CcSEcCtD
Nicotine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000204	0.00301	CbGpPWpGaD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—HES1—brain cancer	0.000203	0.00299	CbGpPWpGaD
Nicotine—MAOB—endocrine gland—brain cancer	0.000202	0.00127	CbGeAlD
Nicotine—Discomfort—Etoposide—brain cancer	0.000202	0.00211	CcSEcCtD
Nicotine—Feeling abnormal—Temozolomide—brain cancer	0.000202	0.00211	CcSEcCtD
Nicotine—Abdominal pain—Carmustine—brain cancer	0.0002	0.00209	CcSEcCtD
Nicotine—Body temperature increased—Carmustine—brain cancer	0.0002	0.00209	CcSEcCtD
Nicotine—Gastrointestinal pain—Temozolomide—brain cancer	0.0002	0.00209	CcSEcCtD
Nicotine—MAOB—head—brain cancer	0.0002	0.00125	CbGeAlD
Nicotine—Vomiting—Hydroxyurea—brain cancer	0.000199	0.00208	CcSEcCtD
Nicotine—CYP2C8—pituitary gland—brain cancer	0.000199	0.00124	CbGeAlD
Nicotine—SLC22A5—medulla oblongata—brain cancer	0.000198	0.00124	CbGeAlD
Nicotine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000198	0.00292	CbGpPWpGaD
Nicotine—Rash—Hydroxyurea—brain cancer	0.000198	0.00206	CcSEcCtD
Nicotine—Confusional state—Etoposide—brain cancer	0.000198	0.00206	CcSEcCtD
Nicotine—Dermatitis—Hydroxyurea—brain cancer	0.000198	0.00206	CcSEcCtD
Nicotine—SLC22A3—central nervous system—brain cancer	0.000197	0.00123	CbGeAlD
Nicotine—Headache—Hydroxyurea—brain cancer	0.000196	0.00205	CcSEcCtD
Nicotine—MAOA—midbrain—brain cancer	0.000196	0.00123	CbGeAlD
Nicotine—CHRNA7—brain—brain cancer	0.000196	0.00123	CbGeAlD
Nicotine—Anaphylactic shock—Etoposide—brain cancer	0.000196	0.00204	CcSEcCtD
Nicotine—CYP2A6—brain—brain cancer	0.000196	0.00123	CbGeAlD
Nicotine—MAOA—Biological oxidations—CYP2C9—brain cancer	0.000196	0.00289	CbGpPWpGaD
Nicotine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000195	0.00288	CbGpPWpGaD
Nicotine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000195	0.00288	CbGpPWpGaD
Nicotine—Urticaria—Temozolomide—brain cancer	0.000195	0.00203	CcSEcCtD
Nicotine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000194	0.00286	CbGpPWpGaD
Nicotine—Body temperature increased—Temozolomide—brain cancer	0.000194	0.00202	CcSEcCtD
Nicotine—Abdominal pain—Temozolomide—brain cancer	0.000194	0.00202	CcSEcCtD
Nicotine—CYP19A1—central nervous system—brain cancer	0.000194	0.00121	CbGeAlD
Nicotine—CHRNA4—brain—brain cancer	0.000193	0.00121	CbGeAlD
Nicotine—MAOA—spinal cord—brain cancer	0.000192	0.0012	CbGeAlD
Nicotine—Tachycardia—Etoposide—brain cancer	0.000191	0.002	CcSEcCtD
Nicotine—CYP19A1—Biological oxidations—CYP2C9—brain cancer	0.000191	0.00282	CbGpPWpGaD
Nicotine—Hyperhidrosis—Etoposide—brain cancer	0.000189	0.00198	CcSEcCtD
Nicotine—CYP19A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000188	0.00278	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000187	0.00276	CbGpPWpGaD
Nicotine—Hypersensitivity—Carmustine—brain cancer	0.000187	0.00195	CcSEcCtD
Nicotine—Nausea—Hydroxyurea—brain cancer	0.000186	0.00194	CcSEcCtD
Nicotine—Hypotension—Etoposide—brain cancer	0.000183	0.00191	CcSEcCtD
Nicotine—CYP2D6—brainstem—brain cancer	0.000183	0.00115	CbGeAlD
Nicotine—CYP2B6—gonad—brain cancer	0.000183	0.00114	CbGeAlD
Nicotine—MAOB—central nervous system—brain cancer	0.000182	0.00114	CbGeAlD
Nicotine—Asthenia—Carmustine—brain cancer	0.000182	0.0019	CcSEcCtD
Nicotine—SLC22A5—midbrain—brain cancer	0.000181	0.00113	CbGeAlD
Nicotine—Hypersensitivity—Temozolomide—brain cancer	0.00018	0.00188	CcSEcCtD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000179	0.00263	CbGpPWpGaD
Nicotine—MAOB—cerebellum—brain cancer	0.000178	0.00112	CbGeAlD
Nicotine—SLC22A5—spinal cord—brain cancer	0.000176	0.00111	CbGeAlD
Nicotine—CYP2C19—endocrine gland—brain cancer	0.000176	0.0011	CbGeAlD
Nicotine—Paraesthesia—Etoposide—brain cancer	0.000176	0.00184	CcSEcCtD
Nicotine—Asthenia—Temozolomide—brain cancer	0.000176	0.00183	CcSEcCtD
Nicotine—Dyspnoea—Etoposide—brain cancer	0.000175	0.00182	CcSEcCtD
Nicotine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000174	0.00257	CbGpPWpGaD
Nicotine—Somnolence—Etoposide—brain cancer	0.000174	0.00182	CcSEcCtD
Nicotine—Diarrhoea—Carmustine—brain cancer	0.000173	0.00181	CcSEcCtD
Nicotine—Pruritus—Temozolomide—brain cancer	0.000173	0.00181	CcSEcCtD
Nicotine—MAOA—endocrine gland—brain cancer	0.000172	0.00108	CbGeAlD
Nicotine—CHRNB2—Circadian rythm related genes—SIRT1—brain cancer	0.000172	0.00254	CbGpPWpGaD
Nicotine—SLC22A4—brain—brain cancer	0.000172	0.00108	CbGeAlD
Nicotine—MAOA—head—brain cancer	0.00017	0.00107	CbGeAlD
Nicotine—Gastrointestinal disorder—Etoposide—brain cancer	0.000169	0.00177	CcSEcCtD
Nicotine—Fatigue—Etoposide—brain cancer	0.000169	0.00176	CcSEcCtD
Nicotine—Dizziness—Carmustine—brain cancer	0.000168	0.00175	CcSEcCtD
Nicotine—Pain—Etoposide—brain cancer	0.000168	0.00175	CcSEcCtD
Nicotine—Constipation—Etoposide—brain cancer	0.000168	0.00175	CcSEcCtD
Nicotine—Diarrhoea—Temozolomide—brain cancer	0.000168	0.00175	CcSEcCtD
Nicotine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000168	0.00247	CbGpPWpGaD
Nicotine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000165	0.00244	CbGpPWpGaD
Nicotine—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000164	0.00242	CbGpPWpGaD
Nicotine—SLC22A1—brain—brain cancer	0.000164	0.00103	CbGeAlD
Nicotine—CYP2D6—telencephalon—brain cancer	0.000163	0.00102	CbGeAlD
Nicotine—Dizziness—Temozolomide—brain cancer	0.000162	0.00169	CcSEcCtD
Nicotine—Feeling abnormal—Etoposide—brain cancer	0.000162	0.00168	CcSEcCtD
Nicotine—CYP2E1—medulla oblongata—brain cancer	0.000161	0.00101	CbGeAlD
Nicotine—Vomiting—Carmustine—brain cancer	0.000161	0.00168	CcSEcCtD
Nicotine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000161	0.00238	CbGpPWpGaD
Nicotine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00016	0.00237	CbGpPWpGaD
Nicotine—Gastrointestinal pain—Etoposide—brain cancer	0.00016	0.00167	CcSEcCtD
Nicotine—Rash—Carmustine—brain cancer	0.00016	0.00167	CcSEcCtD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—HES1—brain cancer	0.00016	0.00236	CbGpPWpGaD
Nicotine—Dermatitis—Carmustine—brain cancer	0.00016	0.00167	CcSEcCtD
Nicotine—Headache—Carmustine—brain cancer	0.000159	0.00166	CcSEcCtD
Nicotine—SLC22A3—brain—brain cancer	0.000156	0.00098	CbGeAlD
Nicotine—Vomiting—Temozolomide—brain cancer	0.000156	0.00162	CcSEcCtD
Nicotine—Urticaria—Etoposide—brain cancer	0.000156	0.00162	CcSEcCtD
Nicotine—MAOA—central nervous system—brain cancer	0.000155	0.000975	CbGeAlD
Nicotine—Body temperature increased—Etoposide—brain cancer	0.000155	0.00162	CcSEcCtD
Nicotine—Abdominal pain—Etoposide—brain cancer	0.000155	0.00162	CcSEcCtD
Nicotine—Rash—Temozolomide—brain cancer	0.000154	0.00161	CcSEcCtD
Nicotine—Dermatitis—Temozolomide—brain cancer	0.000154	0.00161	CcSEcCtD
Nicotine—SLC22A4—Transmembrane transport of small molecules—S100A10—brain cancer	0.000154	0.00227	CbGpPWpGaD
Nicotine—CYP2C8—endocrine gland—brain cancer	0.000154	0.000964	CbGeAlD
Nicotine—CYP19A1—brain—brain cancer	0.000154	0.000964	CbGeAlD
Nicotine—Headache—Temozolomide—brain cancer	0.000153	0.0016	CcSEcCtD
Nicotine—MAOA—cerebellum—brain cancer	0.000152	0.000953	CbGeAlD
Nicotine—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000152	0.00224	CbGpPWpGaD
Nicotine—Nausea—Carmustine—brain cancer	0.000151	0.00157	CcSEcCtD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000146	0.00215	CbGpPWpGaD
Nicotine—Nausea—Temozolomide—brain cancer	0.000146	0.00152	CcSEcCtD
Nicotine—MAOB—brain—brain cancer	0.000145	0.000907	CbGeAlD
Nicotine—Hypersensitivity—Etoposide—brain cancer	0.000144	0.00151	CcSEcCtD
Nicotine—CYP1A2—endocrine gland—brain cancer	0.000144	0.000902	CbGeAlD
Nicotine—CYP2E1—spinal cord—brain cancer	0.000144	0.000902	CbGeAlD
Nicotine—CYP1A1—endocrine gland—brain cancer	0.000142	0.00089	CbGeAlD
Nicotine—Asthenia—Etoposide—brain cancer	0.000141	0.00147	CcSEcCtD
Nicotine—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.00014	0.00207	CbGpPWpGaD
Nicotine—CYP1A1—head—brain cancer	0.00014	0.000879	CbGeAlD
Nicotine—SLC22A5—cerebellum—brain cancer	0.00014	0.000877	CbGeAlD
Nicotine—Pruritus—Etoposide—brain cancer	0.000139	0.00145	CcSEcCtD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—HES1—brain cancer	0.000139	0.00205	CbGpPWpGaD
Nicotine—CYP2B6—endocrine gland—brain cancer	0.000138	0.000865	CbGeAlD
Nicotine—CYP2C9—endocrine gland—brain cancer	0.000137	0.000857	CbGeAlD
Nicotine—CYP2B6—head—brain cancer	0.000136	0.000854	CbGeAlD
Nicotine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000136	0.002	CbGpPWpGaD
Nicotine—Diarrhoea—Etoposide—brain cancer	0.000134	0.0014	CcSEcCtD
Nicotine—CHRNB2—Circadian rythm related genes—CDK4—brain cancer	0.00013	0.00192	CbGpPWpGaD
Nicotine—CHAT—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.00013	0.00191	CbGpPWpGaD
Nicotine—Dizziness—Etoposide—brain cancer	0.00013	0.00135	CcSEcCtD
Nicotine—CYP2E1—endocrine gland—brain cancer	0.000129	0.000812	CbGeAlD
Nicotine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000129	0.00191	CbGpPWpGaD
Nicotine—CYP1A1—central nervous system—brain cancer	0.000128	0.000802	CbGeAlD
Nicotine—CYP2E1—head—brain cancer	0.000128	0.000801	CbGeAlD
Nicotine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000128	0.00188	CbGpPWpGaD
Nicotine—Vomiting—Etoposide—brain cancer	0.000125	0.0013	CcSEcCtD
Nicotine—CYP2B6—central nervous system—brain cancer	0.000124	0.000779	CbGeAlD
Nicotine—Rash—Etoposide—brain cancer	0.000124	0.00129	CcSEcCtD
Nicotine—Dermatitis—Etoposide—brain cancer	0.000123	0.00129	CcSEcCtD
Nicotine—MAOA—brain—brain cancer	0.000123	0.000774	CbGeAlD
Nicotine—Headache—Etoposide—brain cancer	0.000123	0.00128	CcSEcCtD
Nicotine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000123	0.00181	CbGpPWpGaD
Nicotine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000121	0.00178	CbGpPWpGaD
Nicotine—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.00012	0.00177	CbGpPWpGaD
Nicotine—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000118	0.00175	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000117	0.00172	CbGpPWpGaD
Nicotine—CYP2E1—central nervous system—brain cancer	0.000117	0.000731	CbGeAlD
Nicotine—Nausea—Etoposide—brain cancer	0.000116	0.00121	CcSEcCtD
Nicotine—SLC22A3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000116	0.00172	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000116	0.00171	CbGpPWpGaD
Nicotine—CHAT—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000114	0.00168	CbGpPWpGaD
Nicotine—CYP2E1—cerebellum—brain cancer	0.000114	0.000715	CbGeAlD
Nicotine—CHAT—Metabolism—CYP2C9—brain cancer	0.000114	0.00168	CbGpPWpGaD
Nicotine—SLC22A5—brain—brain cancer	0.000114	0.000713	CbGeAlD
Nicotine—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000113	0.00167	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—HES1—brain cancer	0.000113	0.00167	CbGpPWpGaD
Nicotine—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000112	0.00165	CbGpPWpGaD
Nicotine—CYP2C8—brain—brain cancer	0.00011	0.00069	CbGeAlD
Nicotine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.00011	0.00162	CbGpPWpGaD
Nicotine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000105	0.00155	CbGpPWpGaD
Nicotine—CYP3A4—endocrine gland—brain cancer	0.000104	0.000653	CbGeAlD
Nicotine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000104	0.00153	CbGpPWpGaD
Nicotine—CYP2D6—endocrine gland—brain cancer	0.000103	0.000643	CbGeAlD
Nicotine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000102	0.00151	CbGpPWpGaD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000102	0.0015	CbGpPWpGaD
Nicotine—CYP1A1—brain—brain cancer	0.000102	0.000637	CbGeAlD
Nicotine—CYP2D6—head—brain cancer	0.000101	0.000635	CbGeAlD
Nicotine—CYP2B6—brain—brain cancer	9.87e-05	0.000619	CbGeAlD
Nicotine—MAOA—SIDS Susceptibility Pathways—ESR2—brain cancer	9.78e-05	0.00144	CbGpPWpGaD
Nicotine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	9.74e-05	0.00144	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—CYP2C9—brain cancer	9.68e-05	0.00143	CbGpPWpGaD
Nicotine—CHAT—Metabolism—BSG—brain cancer	9.68e-05	0.00143	CbGpPWpGaD
Nicotine—CYP3A4—central nervous system—brain cancer	9.39e-05	0.000589	CbGeAlD
Nicotine—CYP2E1—brain—brain cancer	9.26e-05	0.000581	CbGeAlD
Nicotine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	9.26e-05	0.00137	CbGpPWpGaD
Nicotine—CYP2D6—central nervous system—brain cancer	9.24e-05	0.000579	CbGeAlD
Nicotine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	9.13e-05	0.00135	CbGpPWpGaD
Nicotine—CYP2D6—cerebellum—brain cancer	9.03e-05	0.000566	CbGeAlD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—VEGFA—brain cancer	8.96e-05	0.00132	CbGpPWpGaD
Nicotine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	8.94e-05	0.00132	CbGpPWpGaD
Nicotine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	8.52e-05	0.00126	CbGpPWpGaD
Nicotine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	8.4e-05	0.00124	CbGpPWpGaD
Nicotine—CHAT—Metabolism—IDH1—brain cancer	8.32e-05	0.00123	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—BSG—brain cancer	8.23e-05	0.00122	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	8.04e-05	0.00119	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—CTNNB1—brain cancer	8.01e-05	0.00118	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	7.89e-05	0.00116	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—HES1—brain cancer	7.6e-05	0.00112	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	7.44e-05	0.0011	CbGpPWpGaD
Nicotine—CYP2D6—brain—brain cancer	7.33e-05	0.00046	CbGeAlD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.33e-05	0.00108	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	7.29e-05	0.00108	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	7.21e-05	0.00106	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—TRPC6—brain cancer	7.12e-05	0.00105	CbGpPWpGaD
Nicotine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	7.11e-05	0.00105	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—IDH1—brain cancer	7.08e-05	0.00104	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—VEGFA—brain cancer	7.05e-05	0.00104	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—brain cancer	6.95e-05	0.00103	CbGpPWpGaD
Nicotine—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	6.82e-05	0.00101	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	6.79e-05	0.001	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.78e-05	0.001	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.73e-05	0.000994	CbGpPWpGaD
Nicotine—CHAT—Metabolism—ENO2—brain cancer	6.58e-05	0.000971	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—VEGFA—brain cancer	6.12e-05	0.000903	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	6.06e-05	0.000895	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	5.96e-05	0.00088	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.67e-05	0.000837	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—ENO2—brain cancer	5.6e-05	0.000826	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.57e-05	0.000822	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—TP53—brain cancer	5.53e-05	0.000816	CbGpPWpGaD
Nicotine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.49e-05	0.000811	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—TRPC6—brain cancer	5.37e-05	0.000792	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.36e-05	0.000791	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	5.35e-05	0.00079	CbGpPWpGaD
Nicotine—MAOB—Metabolism—CYP2C9—brain cancer	5.33e-05	0.000787	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	5.15e-05	0.000761	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—VEGFA—brain cancer	4.99e-05	0.000736	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.74e-05	0.0007	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.64e-05	0.000684	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.64e-05	0.000684	CbGpPWpGaD
Nicotine—MAOB—Metabolism—BSG—brain cancer	4.53e-05	0.000669	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CYP2C9—brain cancer	4.51e-05	0.000666	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.34e-05	0.000641	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.29e-05	0.000634	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.98e-05	0.000588	CbGpPWpGaD
Nicotine—MAOB—Metabolism—IDH1—brain cancer	3.9e-05	0.000575	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3.87e-05	0.000571	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	3.85e-05	0.000568	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—BSG—brain cancer	3.83e-05	0.000566	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	3.81e-05	0.000563	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.81e-05	0.000562	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.56e-05	0.000525	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.37e-05	0.000497	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	3.36e-05	0.000496	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.35e-05	0.000495	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CYP2C9—brain cancer	3.34e-05	0.000494	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—IDH1—brain cancer	3.3e-05	0.000487	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.29e-05	0.000485	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CYP2C9—brain cancer	3.26e-05	0.000482	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.18e-05	0.000469	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.14e-05	0.000463	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	3.09e-05	0.000456	CbGpPWpGaD
Nicotine—MAOB—Metabolism—ENO2—brain cancer	3.08e-05	0.000455	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.02e-05	0.000446	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	3.02e-05	0.000446	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PIK3CG—brain cancer	3.02e-05	0.000446	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.96e-05	0.000436	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.96e-05	0.000436	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.91e-05	0.00043	CbGpPWpGaD
Nicotine—MAOA—Metabolism—BSG—brain cancer	2.84e-05	0.00042	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CYP2C9—brain cancer	2.83e-05	0.000418	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—BSG—brain cancer	2.77e-05	0.000409	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.77e-05	0.000409	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CYP2C9—brain cancer	2.64e-05	0.000389	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—ENO2—brain cancer	2.61e-05	0.000385	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.6e-05	0.000384	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CYP2C9—brain cancer	2.6e-05	0.000383	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PIK3CG—brain cancer	2.57e-05	0.000379	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	2.54e-05	0.000374	CbGpPWpGaD
Nicotine—MAOA—Metabolism—IDH1—brain cancer	2.45e-05	0.000361	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—BSG—brain cancer	2.41e-05	0.000355	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—IDH1—brain cancer	2.39e-05	0.000352	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.37e-05	0.00035	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—BSG—brain cancer	2.24e-05	0.000331	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—BSG—brain cancer	2.21e-05	0.000326	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP2C9—brain cancer	2.1e-05	0.000309	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—IDH1—brain cancer	2.07e-05	0.000305	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP2C9—brain cancer	2.05e-05	0.000303	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.03e-05	0.000299	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.94e-05	0.000287	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CYP2C9—brain cancer	1.93e-05	0.000286	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ENO2—brain cancer	1.93e-05	0.000285	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—IDH1—brain cancer	1.93e-05	0.000285	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—IDH1—brain cancer	1.9e-05	0.00028	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ENO2—brain cancer	1.89e-05	0.000278	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—BSG—brain cancer	1.78e-05	0.000263	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP2C9—brain cancer	1.77e-05	0.000262	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—BSG—brain cancer	1.74e-05	0.000258	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—BSG—brain cancer	1.65e-05	0.000243	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ENO2—brain cancer	1.63e-05	0.000241	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP2C9—brain cancer	1.58e-05	0.000234	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—IDH1—brain cancer	1.53e-05	0.000226	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ENO2—brain cancer	1.52e-05	0.000225	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—BSG—brain cancer	1.51e-05	0.000223	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ENO2—brain cancer	1.5e-05	0.000222	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—IDH1—brain cancer	1.5e-05	0.000221	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.46e-05	0.000215	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—IDH1—brain cancer	1.41e-05	0.000209	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PIK3CG—brain cancer	1.41e-05	0.000209	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—BSG—brain cancer	1.35e-05	0.000199	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—IDH1—brain cancer	1.3e-05	0.000191	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—BSG—brain cancer	1.24e-05	0.000183	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.23e-05	0.000182	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—BSG—brain cancer	1.23e-05	0.000181	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ENO2—brain cancer	1.21e-05	0.000179	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PIK3CG—brain cancer	1.2e-05	0.000177	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ENO2—brain cancer	1.19e-05	0.000175	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—IDH1—brain cancer	1.16e-05	0.000171	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.15e-05	0.00017	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ENO2—brain cancer	1.12e-05	0.000165	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—IDH1—brain cancer	1.06e-05	0.000157	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.06e-05	0.000156	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—IDH1—brain cancer	1.06e-05	0.000156	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—BSG—brain cancer	1.05e-05	0.000155	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ENO2—brain cancer	1.03e-05	0.000151	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP2C9—brain cancer	9.52e-06	0.000141	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.43e-06	0.000139	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ENO2—brain cancer	9.15e-06	0.000135	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—IDH1—brain cancer	9.02e-06	0.000133	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3CG—brain cancer	8.87e-06	0.000131	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3CG—brain cancer	8.65e-06	0.000128	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.59e-06	0.000127	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ENO2—brain cancer	8.42e-06	0.000124	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ENO2—brain cancer	8.34e-06	0.000123	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—BSG—brain cancer	8.1e-06	0.000119	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CG—brain cancer	7.5e-06	0.000111	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.34e-06	0.000108	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ENO2—brain cancer	7.13e-06	0.000105	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CG—brain cancer	6.99e-06	0.000103	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—IDH1—brain cancer	6.96e-06	0.000103	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CG—brain cancer	6.89e-06	0.000102	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CG—brain cancer	5.56e-06	8.2e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ENO2—brain cancer	5.5e-06	8.12e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CG—brain cancer	5.44e-06	8.03e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CG—brain cancer	5.13e-06	7.57e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CG—brain cancer	4.7e-06	6.94e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CG—brain cancer	4.2e-06	6.2e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CG—brain cancer	3.86e-06	5.7e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CG—brain cancer	3.83e-06	5.65e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CG—brain cancer	3.27e-06	4.83e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.52e-06	3.73e-05	CbGpPWpGaD
